Fitness, physical activity, and exercise in multiple sclerosis: a systematic review on current evidence for interactions with disease activity and progression

Sebastian Proschinger, Puya Kuhwand, Annette Rademacher, David Walzik, Clemens Warnke, Philipp Zimmer, Niklas Joisten, Sebastian Proschinger, Puya Kuhwand, Annette Rademacher, David Walzik, Clemens Warnke, Philipp Zimmer, Niklas Joisten

Abstract

Background: A moderate to high level of physical activity, including regular exercise, represents an established behavioral and rehabilitative approach for persons with multiple sclerosis (pwMS). Although being increasingly proposed to limit disease activity and progression, high-quality evidence is lacking.

Objective: The objective of the study is to provide valuable information for MS clinicians and researchers by systematically evaluating the current state of evidence (i) whether exercise interventions affect established clinical measures of disease activity and progression in pwMS (i.e., EDSS, relapse rate, lesion load, brain volume, MSFC) and (ii) how the physical activity and fitness level interact with these measures.

Methods: Literature search was conducted in MEDLINE, EMBASE, CINAHL, and SPORTDiscus. Evaluation of evidence quality was done based on standards published by The American Academy of Neurology.

Results: It is likely that exercise improves the MSFC score, whereas the EDSS score, lesion load, and brain volume are likely to remain unchanged over the intervention period. It is possible that exercise decreases the relapse rate. Results from cross-sectional studies indicate beneficial effects of a high physical activity or fitness level on clinical measures which, however, is not corroborated by high evidence quality.

Conclusions: A (supportive) disease-modifying effect of exercise in pwMS cannot be concluded. The rather low evidence quality of existing RCTs underlines the need to conduct more well-designed studies assessing different measures of disease activity or progression as primary end points. A major limitation is the short intervention duration of existing studies which limits meaningful exercise-induced effects on most disability measures. Findings from cross-sectional studies are difficult to contextualize regarding clinical importance due to their solely associative character and low evidence quality.

Prospero registration number: CRD42020188774.

Keywords: Evidence based; Magnetic resonance imaging; Neurorehabilitation; Physical activity; Physical exercise; Systematic review.

Conflict of interest statement

The authors declare that they have no conficts of interest.

© 2022. The Author(s).

Figures

Fig. 1
Fig. 1
PRISMA flow diagram of literature search and results. FES: functional electrical stimulation cycling, RAGT: robot-assisted gait exercises, RCT: randomized controlled trial, CT: controlled trial

References

    1. Dendrou CA, Fugger L, Friese MA. Immunopathology of multiple sclerosis. Nat Rev Immunol. 2015;15:545–558. doi: 10.1038/nri3871.
    1. Walton C, King R, Rechtman L, Kaye W, Leray E, Marrie RA, Robertson N, La Rocca N, Uitdehaag B, van Mei I, Wallin M, Helme A, Angood Napier C, Rijke N, Baneke P. Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition. Mult Scler J. 2020;26:1816–1821. doi: 10.1177/1352458520970841.
    1. Torkildsen O, Myhr KM, Bø L. Disease-modifying treatments for multiple sclerosis - a review of approved medications. Eur J Neurol. 2016;23:18–27. doi: 10.1111/ene.12883.
    1. Khan F, Amatya B. Rehabilitation in multiple sclerosis: a systematic review of systematic reviews. Arch Phys Med Rehabil. 2017;98:353–367. doi: 10.1016/j.apmr.2016.04.016.
    1. Motl RW, Sandroff BM, Kwakkel G, Dalgas U, Feinstein A, Heesen C, Feys P, Thompson AJ. Exercise in patients with multiple sclerosis. Lancet Neurol. 2017 doi: 10.1016/S1474-4422(17)30281-8.
    1. Dalgas U, Langeskov-Christensen M, Stenager E, Riemenschneider M, Hvid LG. Exercise as medicine in multiple sclerosis—time for a paradigm shift: preventive, symptomatic, and disease-modifying aspects and perspectives. Curr Neurol Neurosci Rep. 2019;19:88. doi: 10.1007/s11910-019-1002-3.
    1. Rempe RG, Hartz AMS, Bauer B. Matrix metalloproteinases in the brain and blood-brain barrier: versatile breakers and makers. J Cereb Blood Flow Metab. 2016;36:1481–1507. doi: 10.1177/0271678X16655551.
    1. Zimmer P, Bloch W, Schenk A, Oberste M, Riedel S, Kool J, Langdon D, Dalgas U, Kesselring J, Bansi J. High-intensity interval exercise improves cognitive performance and reduces matrix metalloproteinases-2 serum levels in persons with multiple sclerosis: a randomized controlled trial. Mult Scler J. 2017;24:1635–1644. doi: 10.1177/https.
    1. Negaresh R, Motl RW, Zimmer P, Mokhtarzade M, Baker JS. Effects of exercise training on multiple sclerosis biomarkers of central nervous system and disease status: a systematic review of intervention studies. Eur J Neurol. 2019;26:711–721. doi: 10.1111/ene.13929.
    1. van Munster CEP, Uitdehaag BMJ. Outcome measures in clinical trials for multiple sclerosis. CNS Drugs. 2017;31:217–236. doi: 10.1007/s40263-017-0412-5.
    1. Kjølhede T, Siemonsen S, Wenzel D, Stellmann J-P, Ringgaard S, Pedersen BG, Stenager E, Petersen T, Vissing K, Heesen C, Dalgas U. Can resistance training impact MRI outcomes in relapsing-remitting multiple sclerosis? Mult Scler J. 2018;24:1356–1365. doi: 10.1177/1352458517722645.
    1. Langeskov-Christensen M, Grøndahl Hvid L, Nygaard MKE, Ringgaard S, Jensen HB, Nielsen HH, Petersen T, Stenager E, Eskildsen SF, Dalgas U. Efficacy of high-intensity aerobic exercise on brain MRI measures in multiple sclerosis. Neurology. 2021;96:203–213. doi: 10.1212/WNL.0000000000011241.
    1. Colcombe SJ, Erickson KI, Scalf PE, Kim JS, Prakash R, McAuley E, Elavsky S, Marquez DX, Hu L, Kramer AF. Aerobic exercise training increases brain volume in aging humans. J Gerontol Ser A. 2006;61:1166–1170. doi: 10.1093/gerona/61.11.1166.
    1. Goldberg Y, Fainstein N, Zaychik Y, Hamdi L, Segal S, Nabat H, Touloumi O, Zoidou S, Grigoriadis N, Hoffman JR, Katz A, Ben-hur T, Einstein O. Continuous and interval training attenuate encephalomyelitis by separate immunomodulatory mechanisms. Ann Clin Transl Neurol. 2021;8:190–200. doi: 10.1002/acn3.51267.
    1. Xie Y, Li Z, Wang Y, Xue X, Ma W, Zhang Y, Wang J. Effects of moderate- versus high- intensity swimming training on inflammatory and CD4 + T cell subset profiles in experimental autoimmune encephalomyelitis mice. J Neuroimmunol. 2019;328:60–67. doi: 10.1016/j.jneuroim.2018.12.005.
    1. Souza PS, Gonçalves ED, Pedroso GS, Farias HR, Junqueira SC, Marcon R, Tuon T, Cola M, Silveira PCL, Santos AR, Calixto JB, Souza CT, de Pinho RA, Dutra RC. Physical exercise attenuates experimental autoimmune encephalomyelitis by inhibiting peripheral immune response and blood-brain barrier disruption. Mol Neurobiol. 2017;54:4723–4737. doi: 10.1007/s12035-016-0014-0.
    1. Latimer-Cheung AE, Martin Ginis KA, Hicks AL, Motl RW, Pilutti LA, Duggan M, Wheeler G, Persad R, Smith KM. Development of evidence-informed physical activity guidelines for adults with multiple sclerosis. Arch Phys Med Rehabil. 2013;94:1829. doi: 10.1016/j.apmr.2013.05.015.
    1. Kinnett-Hopkins D, Adamson B, Rougeau K, Motl RW. People with MS are less physically active than healthy controls but as active as those with other chronic diseases: an updated meta-analysis. Mult Scler Relat Disord. 2017;13:38–43. doi: 10.1016/j.msard.2017.01.016.
    1. Neufer PD, Bamman MM, Muoio DM, Bouchard C, Cooper DM, et al. Understanding the cellular and molecular mechanisms of physical activity-induced health benefits. Cell Metab. 2015;22:4–11. doi: 10.1016/j.cmet.2015.05.011.
    1. Sharif K, Watad A, Bragazzi NL, Lichtbroun M, Amital H, Shoenfeld Y. Physical activity and autoimmune diseases: get moving and manage the disease. Autoimmun Rev. 2018;17:53–72. doi: 10.1016/j.autrev.2017.11.010.
    1. Madsen LT, Dalgas U, Hvid LG, Bansi J. A cross-sectional study on the relationship between cardiorespiratory fitness, disease severity and walking speed in persons with multiple sclerosis. Mult Scler Relat Disord. 2019;29:35–40. doi: 10.1016/j.msard.2019.01.024.
    1. Motl RW, Pilutti LA, Hubbard EA, Wetter NC, Sosnoff JJ, Sutton BP. Cardiorespiratory fitness and its association with thalamic, hippocampal, and basal ganglia volumes in multiple sclerosis. NeuroImage Clin. 2015;7:661–666. doi: 10.1016/j.nicl.2015.02.017.
    1. Klaren RE, Hubbard EA, Motl RW, Pilutti LA, Wetter NC, Sutton BP. Objectively measured physical activity is associated with brain volumetric measurements in multiple sclerosis. Behav Neurol. 2015 doi: 10.1155/2015/482536.
    1. Kalb R, Brown TR, Coote S, Costello K, Dalgas U, Garmon E, Giesser B, Halper J, Karpatkin H, Keller J, Ng AV, Pilutti LA, Rohrig A, Van Asch P, Zackowski K, Motl RW. Exercise and lifestyle physical activity recommendations for people with multiple sclerosis throughout the disease course. Mult Scler. 2020;26:1459–1469. doi: 10.1177/1352458520915629.
    1. American College of Sports Medicine . ACSM’s resource manual for guidelines for exercise testing and prescription. Washington: American College of Sports Medicine; 2013.
    1. Riemenschneider M, Hvid LG, Stenager E, Dalgas U. Is there an overlooked “window of opportunity” in MS exercise therapy? Perspectives for early MS rehabilitation. Mult Scler J. 2018;24:886–894. doi: 10.1177/1352458518777377.
    1. Moher D, Liberati A, Tetzlaff J, Altman DG, Altman D, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097. doi: 10.1371/journal.pmed.1000097.
    1. Fischer JS, Rudick RA, Cutter GR, Reingold SC. The multiple sclerosis functional composite measure (MSFC): An integrated approach to MS clinical outcome assessment. Mult Scler. 1999;5:244–250. doi: 10.1177/135245859900500409.
    1. Higgins J, Green S (2011) Cochrane handbook for systematic reviews of interventions 5.1.0. Accessed Mar 2021
    1. Gronseth GS, Cox J, Gloss D, Merillat S, Dittman J (2017) Clinical practice guideline process manual. Am Acad Neurol Accessed Mar 2021
    1. Hoang P, Schoene D, Gandevia S, Smith S, Lord SR. Effects of a home-based step training programme on balance, stepping, cognition and functional performance in people with multiple sclerosis–a randomized controlled trial. Mult Scler. 2016;22:94–103. doi: 10.1177/1352458515579442.
    1. Feys P, Moumdjian L, Van Halewyck F, Wens I, Eijnde BO, Van Wijmeersch B, Popescu V, Van Asch P. Effects of an individual 12-week community-located “start-to-run” program on physical capacity, walking, fatigue, cognitive function, brain volumes, and structures in persons with multiple sclerosis. Mult Scler J. 2019;25:92–103. doi: 10.1177/1352458517740211.
    1. Petajan JH, Gappmaier E, White AT, Spencer MK, Mino L, Hicks RW. Impact of aerobic training on fitness and quality of life in multiple sclerosis. Ann Neurol. 1996;39:432–441. doi: 10.1002/ana.410390405.
    1. Niwald M, Redlicka J, Miller E. The effects of aerobic training on the functional status, quality of life, the level of fatigue and disability in patients with multiple sclerosis: a preliminary report. Aktual Neurol. 2017;17:15–22. doi: 10.15557/AN.2017.0002.
    1. Rasova K, Havrdova E, Brandejsky P, Zálisová M, Foubikova B, Martinkova P. Comparison of the influence of different rehabilitation programmes on clinical, spirometric and spiroergometric parameters in patients with multiple sclerosis. Mult Scler. 2006;12:227–234. doi: 10.1191/135248506ms1248oa.
    1. Miller L, Paul L, Mattison P, McFadyen A. Evaluation of a home-based physiotherapy programme for those with moderate to severe multiple sclerosis: a randomized controlled pilot study. Clin Rehabil. 2011;25:720–730. doi: 10.1177/0269215511398376.
    1. Moradi M, Sahraian MA, Aghsaie A, Kordi MR, Meysamie A, Abolhasani M, Sobhani V. Effects of eight-week resistance training program in men with multiple sclerosis. Asian J Sports Med. 2015;6:e22838. doi: 10.5812/asjsm.6(2)2015.22838.
    1. Bjarnadottir OH, Konradsdottir AD, Reynisdottir K, Olafsson E. Multiple sclerosis and brief moderate exercise. A randomised study. Mult Scler. 2007;13:776–782. doi: 10.1177/1352458506073780.
    1. Golzari Z, Shabkhiz F, Soudi S, Kordi MR, Hashemi SM. Combined exercise training reduces IFN-γ and IL-17 levels in the plasma and the supernatant of peripheral blood mononuclear cells in women with multiple sclerosis. Int Immunopharmacol. 2010;10:1415–1419. doi: 10.1016/j.intimp.2010.08.008.
    1. Grazioli E, Tranchita E, Borriello G, Cerulli C, Minganti C, Parisi A. The effects of concurrent resistance and aerobic exercise training on functional status in patients with multiple sclerosis. Curr Sports Med Rep. 2019;18:452–457. doi: 10.1249/JSR.0000000000000661.
    1. Romberg A, Virtanen A, Ruutiainen J. Long-term exercise improves functional impairment but not quality of life in multiple sclerosis. J Neurol. 2005;252:839–845. doi: 10.1007/s00415-005-0759-2.
    1. Sangelaji B, Nabavi SM, Estebsari F, Banshi MR, Rashidian H, Jamshidi E, Dastoorpour M. Effect of combination exercise therapy on walking distance, postural balance, fatigue and quality of life in multiple sclerosis patients: a clinical trial study. Iran Red Crescent Med J. 2014;16:e17173. doi: 10.5812/ircmj.17173.
    1. de Oliveira G, Tavares MCCGF, de Faria OJD, Rodrigues MR, Santaella DF. Yoga training has positive effects on postural balance and its influence on activities of daily living in people with multiple sclerosis: a pilot study. Explor J Sci Heal. 2016;12:325–332. doi: 10.1016/j.explore.2016.06.005.
    1. Konečný L, Pospíšil P, Vank P, Mífková L, Pochmonová J, Havelková A, Siegelová J, Dobšák P. Combination of aerobic and resistant training in multiple sclerosis. Scr Med (Brno) 2010;83:98–106.
    1. Ertekin Ö, Özakbaş S, Idiman E, Candan Algun Z. Quality of life, fatigue and balance improvements after home-based exercise program in multiple sclerosis patients. Arch neuropsychiatry. 2012;49:33–38. doi: 10.4274/npa.y6091.
    1. Ertekin Ö, Özakbaş S, Idiman E, Algun ZC. The effects of low and severe disability on walking abilities and quality of life in multiple sclerosis patients: 6-month follow-up study. Arch neuropsychiatry. 2013;50:23–29. doi: 10.4274/npa.y6213.
    1. Velikonja O, Čurić K, Ožura A, Jazbec SSSŠ, Curić K, Ozura A, Jazbec SSSŠ. Influence of sports climbing and yoga on spasticity, cognitive function, mood and fatigue in patients with multiple sclerosis. Clin Neurol Neurosurg. 2010;112:597–601. doi: 10.1016/j.clineuro.2010.03.006.
    1. Kalron A, Menascu S, Hoffmann C, Achiron A. The importance of physical activity to preserve hippocampal volume in people with multiple sclerosis: a structural MRI study. J Neurol. 2020;267:3723–3730. doi: 10.1007/s00415-020-10085-1.
    1. Bahmani DS, Esmaeili L, Shaygannejad V, Gerber M, Kesselring J, Lang UE, Holsboer-Trachsler E, Brand S. Stability of mental toughness, sleep disturbances, and physical activity in patients with multiple sclerosis (MS): a longitudinal and pilot study. Front Psychiatry. 2018;9:1–8. doi: 10.3389/fpsyt.2018.00182.
    1. Kalron A, Frid L, Aloni R, Menascu S, Givon U. Physical activity participation according to the pyramidal, sensory, and cerebellar functional systems in multiple sclerosis. J Neural Transm. 2019;126:1609–1616. doi: 10.1007/s00702-019-02099-5.
    1. Fjeldstad C, Fjeldstad AS, Pardo G. Use of accelerometers to measure real-life physical activity in ambulatory individuals with multiple sclerosis. Int J MS Care. 2015;17:215–220. doi: 10.7224/1537-2073.2014-037.
    1. Shema-Shiratzky S, Hillel I, Mirelman A, Regev K, Hsieh KL, Karni A, Devos H, Sosnoff JJ, Hausdorff JM. A wearable sensor identifies alterations in community ambulation in multiple sclerosis: contributors to real-world gait quality and physical activity. J Neurol. 2020;267:1912–1921. doi: 10.1007/s00415-020-09759-7.
    1. Block VJ, Bove R, Zhao C, Garcha P, Graves J, Romeo AR, Green AJ, Allen DD, Hollenbach JA, Olgin JE, Marcus GM, Pletcher MJ, Cree BAC, Gelfand JM. Association of continuous assessment of step count by remote monitoring with disability progression among adults with multiple sclerosis. JAMA Netw Open. 2019;2:e190570. doi: 10.1001/jamanetworkopen.2019.0570.
    1. Block VJ, Lizée A, Crabtree-Hartman E, Bevan CJ, Graves JS, et al. Continuous daily assessment of multiple sclerosis disability using remote step count monitoring. J Neurol. 2017;264:316–326. doi: 10.1007/s00415-016-8334-6.
    1. Cavanaugh JT, Gappmaier VO, Dibble LE, Gappmaier E. Ambulatory activity in individuals with multiple sclerosis. J Neurol Phys Ther. 2011;35:26–33. doi: 10.1097/NPT.0b013e3182097190.
    1. Merkelbach S, Schulz H, Kölmel HW, Gora G, Klingelhöfer J, Dachsel R, Hoffmann F, Polzer U. Fatigue, sleepiness, and physical activity in patients with multiple sclerosis. J Neurol. 2011;258:74–79. doi: 10.1007/s00415-010-5684-3.
    1. Shammas L, Zentek T, von Haaren B, Schlesinger S, Hey S, Rashid A. Home-based system for physical activity monitoring in patients with multiple sclerosis (Pilot study) Biomed Eng Online. 2014;13:10. doi: 10.1186/1475-925X-13-10.
    1. Chaves AR, Kelly LP, Moore CS, Stefanelli M, Ploughman M. Prolonged cortical silent period is related to poor fitness and fatigue, but not tumor necrosis factor, in Multiple Sclerosis. Clin Neurophysiol. 2019;130:474–483. doi: 10.1016/j.clinph.2018.12.015.
    1. Foglio K, Clini E, Facchetti D, Vitacca M, Marangoni S, Bonomelli M, Ambrosino N. Respiratory muscle function and exercise capacity in multiple sclerosis. Eur Respir J. 1994;7:23–28. doi: 10.1183/09031936.94.07010023.
    1. Kerling A, Keweloh K, Tegtbur U, Kück M, Grams L, Horstmann H, Windhagen A. Physical capacity and quality of life in patients with multiple sclerosis. NeuroRehabilitation. 2014;35:97–104. doi: 10.3233/NRE-141099.
    1. Fritz NE, Keller J, Calabresi PA, Zackowski KM. Quantitative measures of walking and strength provide insight into brain corticospinal tract pathology in multiple sclerosis. NeuroImage Clin. 2017;14:490–498. doi: 10.1016/j.nicl.2017.02.006.
    1. Pilutti LA, Sandroff BM, Klaren RE, Learmonth YC, Platta ME, Hubbard EA, Stratton M, Motl RW. Physical fitness assessment across the disability spectrum in persons with multiple sclerosis: a comparison of testing modalities. J Neurol Phys Ther. 2015;39:241–249. doi: 10.1097/NPT.0000000000000099.
    1. Konečný L, Pospíšil P, Dufek M, Drlíková L, Anbais FH, Erajhi AA, Dobšák P, Vank P, Siegelová J. Functional impairment in multiple sclerosis. Scr Medica. 2007;80:225–232.
    1. Heine M, Wens I, Langeskov-Christensen M, Verschuren O, Eijnde BO, Kwakkel G, Dalgas U. Cardiopulmonary fitness is related to disease severity in multiple sclerosis. Mult Scler. 2016;22:231–238. doi: 10.1177/1352458515581437.
    1. Rasova K, Brandejsky P, Havrdova E, Zalisova M, Rexova P. Spiroergometric and spirometric parameters in patients with multiple sclerosis: are there any links between these parameters and fatigue, depression, neurological impairment, disability, handicap and quality of life in multiple sclerosis? Mult Scler. 2005;11:213–221. doi: 10.1191/1352458505ms1155oa.
    1. Romberg A, Virtanen A, Aunola S, Karppi SL, Karanko H, Ruutiainen J. Exercise capacity, disability and leisure physical activity of subjects with multiple sclerosis. Mult Scler. 2004;10:212–218. doi: 10.1191/1352458504ms1001oa.
    1. Prakash RS, Snook EM, Motl RW, Kramer AF. Aerobic fitness is associated with gray matter volume and white matter integrity in multiple sclerosis. Brain Res. 2010;1341:41–51. doi: 10.1016/j.brainres.2009.06.063.
    1. Thompson AJ, Baranzini SE, Geurts J, Hemmer B, Ciccarelli O. Multiple sclerosis. Lancet. 2018;391:1622–1636. doi: 10.1016/S0140-6736(18)30481-1.
    1. Braley TJ, Chervin RD. Fatigue in multiple sclerosis: mechanisms, evaluation, and treatment. Sleep. 2010;33:1061–1067. doi: 10.1093/sleep/33.8.1061.
    1. Firth J, Stubbs B, Vancampfort D, Schuch F, Lagopoulos J, Rosenbaum S, Ward PB. Effect of aerobic exercise on hippocampal volume in humans: a systematic review and meta-analysis. Neuroimage. 2018;166:230–238. doi: 10.1016/j.neuroimage.2017.11.007.
    1. Mattson MP, Moehl K, Ghena N, Schmaedick M, Cheng A. Intermittent metabolic switching, neuroplasticity and brain health. Nat Rev Neurosci. 2018;19:63–80. doi: 10.1038/nrn.2017.156.
    1. Stuart CM, Varatharaj A, Domjan J, Philip S, Galea I, et al. Physical activity monitoring to assess disability progression in multiple sclerosis. Mult Scler J. 2020 doi: 10.1177/2055217320975185.
    1. Wittfeld K, Jochem C, Dörr M, Schminke U, Gläser S, Bahls M, Markus MRP, Felix SB, Leitzmann MF, Ewert R, Bülow R, Völzke H, Janowitz D, Baumeister SE, Grabe HJ. Cardiorespiratory fitness and gray matter volume in the temporal, frontal, and cerebellar regions in the general population. Mayo Clin Proc. 2020;95:44–56. doi: 10.1016/j.mayocp.2019.05.030.
    1. Burns JM, Cronk BB, Anderson HS, Donnelly JE, Thomas GP, Harsha A, Brooks WM, Swerdlow RH. Cardiorespiratory fitness and brain atrophy in early Alzheimer disease. Neurology. 2008;71:210–216. doi: 10.1212/01.wnl.0000317094.86209.cb.
    1. Kalincik T, Cutter G, Spelman T, Jokubaitis V, Havrdova E, et al. Defining reliable disability outcomes in multiple sclerosis. Brain. 2015;138:3287–3298. doi: 10.1093/brain/awv258.
    1. Nazareth TA, Rava AR, Polyakov JL, Banfe EN, Waltrip Ii RW, Zerkowski KB, Herbert LB. Relapse prevalence, symptoms, and health care engagement: patient insights from the Multiple Sclerosis in America 2017 survey. Mult Scler Relat Disord. 2018;26:219–234. doi: 10.1016/j.msard.2018.09.002.
    1. Vidal-Jordana A, Sastre-Garriga J, Rovira A, Montalban X. Treating relapsing–remitting multiple sclerosis: therapy effects on brain atrophy. J Neurol. 2015;262:2617–2626. doi: 10.1007/s00415-015-7798-0.
    1. Giorgio A, Battaglini M, Smith SM, De Stefano N. Brain atrophy assessment in multiple sclerosis: importance and limitations. Neuroimaging Clin N Am. 2008;18:675–686. doi: 10.1016/j.nic.2008.06.007.
    1. Gharakhanlou R, Wesselmann L, Rademacher A, Lampit A, Negaresh R, Kaviani M, Oberste M, Motl RW, Sandroff BM, Bansi J, Baker JS, Heesen C, Zimmer P, Javelle F. Exercise training and cognitive performance in persons with multiple sclerosis: a systematic review and multilevel meta-analysis of clinical trials. Mult Scler J. 2020 doi: 10.1177/1352458520917935.
    1. Walsh NP, Gleeson MM, Shephard RJ, Gleeson MM, Woods JA, Bishop NC, Fleshner M, Green C, Pedersen BK, Hoffman-Goetz L, Rogers CJ, Northoff H, Abbasi A, Simon P. Institutional Repository Position statement part one : immune function and exercise. Exerc Immunol Rev. 2011;17:6–63.
    1. Joisten N, Proschinger S, Rademacher A, Schenk A, Bloch W, Warnke C, Gonzenbach R, Kool J, Bansi J, Zimmer P. High-intensity interval training reduces neutrophil-to-lymphocyte ratio in persons with multiple sclerosis during inpatient rehabilitation. Mult Scler J. 2020 doi: 10.1177/1352458520951382.
    1. Hasselbalch IC, Søndergaard HB, Koch-Henriksen N, Olsson A, Ullum H, Sellebjerg F, Oturai AB. The neutrophil-to-lymphocyte ratio is associated with multiple sclerosis. Mult Scler J Exp Transl Clin. 2018 doi: 10.1177/2055217318813183.
    1. Hemond CC, Glanz BI, Bakshi R, Chitnis T, Healy BC. The neutrophil-to-lymphocyte and monocyte-to-lymphocyte ratios are independently associated with neurological disability and brain atrophy in multiple sclerosis. BMC Neurol. 2019;19:1–10. doi: 10.1186/s12883-019-1245-2.
    1. Sleiman SF, Henry J, Al-Haddad R, El Hayek L, Haidar EA, Stringer T, Ulja D, Karuppagounder SS, Holson EB, Ratan RR, Ninan I, Chao MV. Exercise promotes the expression of brain derived neurotrophic factor (BDNF) through the action of the ketone body β- hydroxybutyrate. Elife. 2016;5:1–21. doi: 10.7554/eLife.15092.
    1. Agudelo LZ, Femenía T, Orhan F, Porsmyr-Palmertz M, Goiny M, et al. Skeletal muscle PGC-1α1 modulates kynurenine metabolism and mediates resilience to stress-induced depression. Cell. 2014;159:33–45. doi: 10.1016/j.cell.2014.07.051.
    1. Joisten N, Rademacher A, Warnke C, Proschinger S, Schenk A, Walzik D, Knoop A, Thevis M, Steffen F, Bittner S, Gonzenbach R, Kool J, Bloch W, Bansi J, Zimmer P. Exercise Diminishes Plasma Neurofilament Light Chain and Reroutes the Kynurenine Pathway in Multiple Sclerosis. Neurol Neuroimmunol Neuroinflamm. 2021;8:1–11. doi: 10.1212/NXI.0000000000000982.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel